Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.48 |
| ▸ | CCR5 | P51681 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | CCR8 | P51685 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.35 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18774829 | 0.79 | CCR1 (0.65) | CCR1CCR5CCR8CYP1A2LMNA | |
| SCHEMBL8023024 | 0.79 | PDE10A (0.41) | CCR1CCR5RAB9ACCR8POLB | |
| SCHEMBL9539910 | 0.78 | CYP1A2 (0.52) | CCR1CCR5CCR8CYP1A2LMNA | |
| SCHEMBL4957696 | 0.77 | NR4A2 (0.40) | CCR1CCR5RAB9ACCR8CYP1A2 | |
| SCHEMBL28950361 | 0.77 | LMNA (0.54) | CCR1CCR5CCR8CYP1A2LMNA | |
| SCHEMBL16902262 | 0.76 | CCR1 (0.76) | CCR1CCR5RAB9ACCR8CYP1A2 | |
| SCHEMBL17133514 | 0.75 | CYP1A2 (0.54) | CCR1CCR5CCR8CYP1A2LMNA | |
| SCHEMBL17051638 | 0.74 | CCR1 (0.60) | CCR1CCR5RAB9ACCR8CYP1A2 | |
| SCHEMBL17532742 | 0.73 | KDM4E (0.52) | CCR1CCR5RAB9ACYP1A2LMNA | |
| SCHEMBL874271 | 0.73 | LMNA (0.67) | CCR1CCR5RAB9ACCR8CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015743-A1 | MEDIATED HYDROGEN ANODE FOR USE IN REDUCTIVE ELECTROSYNTHESIS | WISCONSIN ALUMNI RES FOUND (US) | 2026-01-15 | — | — | US | claimed |
| CN-118324819-A | Ruthenium complex and preparation method and application thereof | 中山大学 | 2024-07-12 | — | — | CN | claimed |
| CN-117924171-A | Phenanthrone derivative and synthesis method thereof | 华南理工大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117776958-A | Aromatic hydrocarbon carboxylic acid meta-position alkylation product and synthesis method thereof | 华南理工大学 | 2024-03-29 | — | — | CN | claimed |
| CN-116239635-A | 2-amino-8-hydroxyquinoline nickel complex for resisting drug-resistant ovarian cancer and preparation method thereof | 玉林师范学院 | 2023-06-09 | — | — | CN | claimed |
| CN-116081648-A | Prussian Bai Zheng pole material and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-114890856-A | Method for synthesizing 2,2' -biphenyl-1-carboxylic acid derivative | 华南理工大学 | 2022-08-12 | — | — | CN | claimed |
| CN-114657618-A | Electroplating pretreatment process for aluminum base material PCB circuit board and application thereof | 南通麦特隆新材料科技有限公司 | 2022-06-24 | — | — | CN | claimed |
| CN-113897599-A | Production process and method of chemical copper | 深圳市正天伟科技有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-113388829-A | Electroless copper plating solution and method for plating copper on substrate by using electroless copper plating solution | 惠州金晟新电子科技有限公司 | 2021-09-14 | — | — | CN | claimed |
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, LLC | 2008-03-06 | — | — | US | claimed |
| WO-2004078874-A2 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | POLAROID CORPORATION (US) | 2004-09-16 | — | — | WO | claimed |
| US-20040168748-A1 | Addition product, production and use thereof as corrosion inhibitor | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-09-02 | — | — | US | claimed |
| US-20040171817-A1 | Novel dye complexes and use thereof in imaging members and methods | ZINK HOLDINGS LLC | 2004-09-02 | — | — | US | claimed |
| EP-1373599-A2 | ADDITION PRODUCT, PRODUCTION AND USE THEREOF AS CORROSION INHIBITOR | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-01-02 | — | — | EP | claimed |
| WO-2002090619-A2 | ADDITION PRODUCT, PRODUCTION AND USE THEREOF AS CORROSION INHIBITOR | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-11-14 | — | — | WO | claimed |
| EP-0853064-B1 | Process for the synthesis of hydrogen peroxide | ENICHEM SPA (IT) | 2000-02-23 | — | — | EP | claimed |
| EP-0808796-B1 | Process for the preparation of hydrogen peroxide | ENICHEM SPA (IT) | 2000-02-09 | — | — | EP | claimed |
| EP-0894783-A1 | Process for the synthesis of phenol from benzene | Enichem S.p.A. (IT) | 1999-02-03 | — | — | EP | claimed |
| EP-0853064-A1 | Process for the synthesis of hydrogen peroxide | ENICHEM S.p.A. (IT) | 1998-07-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015743-A1 | MEDIATED HYDROGEN ANODE FOR USE IN REDUCTIVE ELECTROSYNTHESIS | HAO2, HACL2, HVCN1 | CCR1 2861/4885CCR5 4291/4885RAB9A 3015/4885 |
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | DBI, HSPE1, ABCB7 | CCR1 3141/4885CCR5 3206/4885RAB9A 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.